nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—ALB—chronic obstructive pulmonary disease	0.325	1	CbGaD
Sulfamethoxazole—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0891	0.204	CbGbCtD
Sulfamethoxazole—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0514	0.118	CbGbCtD
Sulfamethoxazole—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0473	0.108	CbGbCtD
Sulfamethoxazole—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0473	0.108	CbGbCtD
Sulfamethoxazole—ALB—Prednisone—chronic obstructive pulmonary disease	0.0369	0.0844	CbGbCtD
Sulfamethoxazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0363	0.0831	CbGbCtD
Sulfamethoxazole—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0359	0.0821	CbGbCtD
Sulfamethoxazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0245	0.0562	CbGbCtD
Sulfamethoxazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0234	0.0536	CbGbCtD
Sulfamethoxazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0209	0.0477	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0122	0.028	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0116	0.0265	CbGbCtD
Sulfamethoxazole—NAT1—respiratory system—chronic obstructive pulmonary disease	0.00199	0.269	CbGeAlD
Sulfamethoxazole—NAT1—bronchus—chronic obstructive pulmonary disease	0.00164	0.222	CbGeAlD
Sulfamethoxazole—NAT1—trachea—chronic obstructive pulmonary disease	0.00147	0.199	CbGeAlD
Sulfamethoxazole—NAT1—lung—chronic obstructive pulmonary disease	0.00106	0.143	CbGeAlD
Sulfamethoxazole—Sulfamethazine—ALB—chronic obstructive pulmonary disease	0.000577	0.268	CrCbGaD
Sulfamethoxazole—Dapsone—MPO—chronic obstructive pulmonary disease	0.000575	0.267	CrCbGaD
Sulfamethoxazole—Sulfamerazine—ALB—chronic obstructive pulmonary disease	0.000564	0.262	CrCbGaD
Sulfamethoxazole—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000491	0.00372	CcSEcCtD
Sulfamethoxazole—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000491	0.00372	CcSEcCtD
Sulfamethoxazole—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000488	0.0037	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000485	0.00367	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000482	0.00366	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000481	0.00365	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00048	0.00364	CcSEcCtD
Sulfamethoxazole—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000472	0.00358	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000468	0.00355	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000467	0.00354	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.00352	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000464	0.00352	CcSEcCtD
Sulfamethoxazole—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000464	0.00352	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000464	0.00352	CcSEcCtD
Sulfamethoxazole—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00046	0.00349	CcSEcCtD
Sulfamethoxazole—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00046	0.00349	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.00348	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000457	0.00346	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00343	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00343	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00342	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00342	CcSEcCtD
Sulfamethoxazole—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000446	0.00338	CcSEcCtD
Sulfamethoxazole—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000446	0.00338	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00336	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000442	0.00335	CcSEcCtD
Sulfamethoxazole—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000442	0.00335	CcSEcCtD
Sulfamethoxazole—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000442	0.00335	CcSEcCtD
Sulfamethoxazole—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.00334	CcSEcCtD
Sulfamethoxazole—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00044	0.00333	CcSEcCtD
Sulfamethoxazole—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000439	0.00333	CcSEcCtD
Sulfamethoxazole—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.00333	CcSEcCtD
Sulfamethoxazole—Sulfamethizole—ALB—chronic obstructive pulmonary disease	0.000438	0.203	CrCbGaD
Sulfamethoxazole—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00331	CcSEcCtD
Sulfamethoxazole—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00331	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000433	0.00328	CcSEcCtD
Sulfamethoxazole—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00326	CcSEcCtD
Sulfamethoxazole—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000429	0.00325	CcSEcCtD
Sulfamethoxazole—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00324	CcSEcCtD
Sulfamethoxazole—Tension—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00324	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00324	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00323	CcSEcCtD
Sulfamethoxazole—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.00322	CcSEcCtD
Sulfamethoxazole—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000424	0.00321	CcSEcCtD
Sulfamethoxazole—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.00321	CcSEcCtD
Sulfamethoxazole—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000423	0.00321	CcSEcCtD
Sulfamethoxazole—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000417	0.00316	CcSEcCtD
Sulfamethoxazole—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00314	CcSEcCtD
Sulfamethoxazole—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00312	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000412	0.00312	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000407	0.00308	CcSEcCtD
Sulfamethoxazole—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00306	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000402	0.00305	CcSEcCtD
Sulfamethoxazole—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00303	CcSEcCtD
Sulfamethoxazole—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.00302	CcSEcCtD
Sulfamethoxazole—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00302	CcSEcCtD
Sulfamethoxazole—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00302	CcSEcCtD
Sulfamethoxazole—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000391	0.00296	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000388	0.00294	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000383	0.0029	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000381	0.00289	CcSEcCtD
Sulfamethoxazole—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00289	CcSEcCtD
Sulfamethoxazole—Cough—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00289	CcSEcCtD
Sulfamethoxazole—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00285	CcSEcCtD
Sulfamethoxazole—Cough—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00283	CcSEcCtD
Sulfamethoxazole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000372	0.00282	CcSEcCtD
Sulfamethoxazole—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00282	CcSEcCtD
Sulfamethoxazole—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00282	CcSEcCtD
Sulfamethoxazole—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00282	CcSEcCtD
Sulfamethoxazole—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00282	CcSEcCtD
Sulfamethoxazole—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00037	0.00281	CcSEcCtD
Sulfamethoxazole—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00281	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00037	0.0028	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00037	0.0028	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000369	0.0028	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.0028	CcSEcCtD
Sulfamethoxazole—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00276	CcSEcCtD
Sulfamethoxazole—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00276	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00274	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000361	0.00273	CcSEcCtD
Sulfamethoxazole—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00272	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000356	0.0027	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.0027	CcSEcCtD
Sulfamethoxazole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00266	CcSEcCtD
Sulfamethoxazole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00266	CcSEcCtD
Sulfamethoxazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000351	0.00266	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00265	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00265	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000349	0.00264	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000349	0.00264	CcSEcCtD
Sulfamethoxazole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00262	CcSEcCtD
Sulfamethoxazole—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00262	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000345	0.00261	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00259	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00259	CcSEcCtD
Sulfamethoxazole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000339	0.00257	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00255	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000333	0.00252	CcSEcCtD
Sulfamethoxazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.00251	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.0025	CcSEcCtD
Sulfamethoxazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00248	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000325	0.00246	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.00246	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000324	0.00246	CcSEcCtD
Sulfamethoxazole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00244	CcSEcCtD
Sulfamethoxazole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00244	CcSEcCtD
Sulfamethoxazole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00243	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00032	0.00243	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00242	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000318	0.00241	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00241	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00241	CcSEcCtD
Sulfamethoxazole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00239	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00238	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00238	CcSEcCtD
Sulfamethoxazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00237	CcSEcCtD
Sulfamethoxazole—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000311	0.0421	CbGeAlD
Sulfamethoxazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00234	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00233	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00233	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00233	CcSEcCtD
Sulfamethoxazole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00233	CcSEcCtD
Sulfamethoxazole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00233	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00232	CcSEcCtD
Sulfamethoxazole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.0023	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000301	0.00228	CcSEcCtD
Sulfamethoxazole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000301	0.00228	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00227	CcSEcCtD
Sulfamethoxazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.00225	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000296	0.00225	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00224	CcSEcCtD
Sulfamethoxazole—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000296	0.00224	CcSEcCtD
Sulfamethoxazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000295	0.00224	CcSEcCtD
Sulfamethoxazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000295	0.00223	CcSEcCtD
Sulfamethoxazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000293	0.00222	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00222	CcSEcCtD
Sulfamethoxazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000292	0.00221	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000291	0.00221	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000291	0.00221	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.0022	CcSEcCtD
Sulfamethoxazole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.0022	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000285	0.00216	CcSEcCtD
Sulfamethoxazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00214	CcSEcCtD
Sulfamethoxazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00214	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00213	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00213	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00213	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00213	CcSEcCtD
Sulfamethoxazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00213	CcSEcCtD
Sulfamethoxazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00211	CcSEcCtD
Sulfamethoxazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00211	CcSEcCtD
Sulfamethoxazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000278	0.00211	CcSEcCtD
Sulfamethoxazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000277	0.0021	CcSEcCtD
Sulfamethoxazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.00209	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00209	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00209	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00208	CcSEcCtD
Sulfamethoxazole—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000274	0.037	CbGeAlD
Sulfamethoxazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00202	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00201	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00201	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00199	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00199	CcSEcCtD
Sulfamethoxazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000262	0.00199	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00195	CcSEcCtD
Sulfamethoxazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00194	CcSEcCtD
Sulfamethoxazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00194	CcSEcCtD
Sulfamethoxazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00191	CcSEcCtD
Sulfamethoxazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00191	CcSEcCtD
Sulfamethoxazole—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000251	0.0339	CbGeAlD
Sulfamethoxazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00025	0.0019	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00188	CcSEcCtD
Sulfamethoxazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00187	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00185	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00185	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00183	CcSEcCtD
Sulfamethoxazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00183	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00181	CcSEcCtD
Sulfamethoxazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.0018	CcSEcCtD
Sulfamethoxazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00178	CcSEcCtD
Sulfamethoxazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00178	CcSEcCtD
Sulfamethoxazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00175	CcSEcCtD
Sulfamethoxazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00023	0.00175	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00174	CcSEcCtD
Sulfamethoxazole—PTGS1—trachea—chronic obstructive pulmonary disease	0.00023	0.0311	CbGeAlD
Sulfamethoxazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00172	CcSEcCtD
Sulfamethoxazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00172	CcSEcCtD
Sulfamethoxazole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.0017	CcSEcCtD
Sulfamethoxazole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000225	0.0017	CcSEcCtD
Sulfamethoxazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.0017	CcSEcCtD
Sulfamethoxazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000224	0.0017	CcSEcCtD
Sulfamethoxazole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00169	CcSEcCtD
Sulfamethoxazole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00169	CcSEcCtD
Sulfamethoxazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00169	CcSEcCtD
Sulfamethoxazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00168	CcSEcCtD
Sulfamethoxazole—Rash—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00167	CcSEcCtD
Sulfamethoxazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00167	CcSEcCtD
Sulfamethoxazole—Depression—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00166	CcSEcCtD
Sulfamethoxazole—Headache—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00166	CcSEcCtD
Sulfamethoxazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00164	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00163	CcSEcCtD
Sulfamethoxazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00162	CcSEcCtD
Sulfamethoxazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00161	CcSEcCtD
Sulfamethoxazole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00161	CcSEcCtD
Sulfamethoxazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00161	CcSEcCtD
Sulfamethoxazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.0016	CcSEcCtD
Sulfamethoxazole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000212	0.0016	CcSEcCtD
Sulfamethoxazole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.0016	CcSEcCtD
Sulfamethoxazole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00157	CcSEcCtD
Sulfamethoxazole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.00155	CcSEcCtD
Sulfamethoxazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00151	CcSEcCtD
Sulfamethoxazole—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00149	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00147	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.00146	CcSEcCtD
Sulfamethoxazole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000184	0.0014	CcSEcCtD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000181	0.00187	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00018	0.00186	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000179	0.00185	CbGpPWpGaD
Sulfamethoxazole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00135	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000178	0.00183	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00182	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00181	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00181	CbGpPWpGaD
Sulfamethoxazole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00132	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000174	0.0018	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000174	0.0018	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00179	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000173	0.00179	CbGpPWpGaD
Sulfamethoxazole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00131	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000172	0.00177	CbGpPWpGaD
Sulfamethoxazole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000172	0.0013	CcSEcCtD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000171	0.00177	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000171	0.00177	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000168	0.00173	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000165	0.00171	CbGpPWpGaD
Sulfamethoxazole—PTGS1—lung—chronic obstructive pulmonary disease	0.000165	0.0223	CbGeAlD
Sulfamethoxazole—NAT1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.00016	0.00165	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000158	0.00164	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000158	0.00164	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000157	0.00163	CbGpPWpGaD
Sulfamethoxazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00119	CcSEcCtD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00162	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000155	0.0016	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.0016	CbGpPWpGaD
Sulfamethoxazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00117	CcSEcCtD
Sulfamethoxazole—UGT1A9—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000154	0.00159	CbGpPWpGaD
Sulfamethoxazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.00116	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00157	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000149	0.00154	CbGpPWpGaD
Sulfamethoxazole—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00113	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000148	0.00153	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00152	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000147	0.00152	CbGpPWpGaD
Sulfamethoxazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00111	CcSEcCtD
Sulfamethoxazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00111	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000145	0.0011	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000145	0.0015	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.00149	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.00148	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00147	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.00108	CcSEcCtD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000141	0.00146	CbGpPWpGaD
Sulfamethoxazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00106	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00104	CcSEcCtD
Sulfamethoxazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00103	CcSEcCtD
Sulfamethoxazole—UGT1A9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000135	0.0014	CbGpPWpGaD
Sulfamethoxazole—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00101	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000133	0.00138	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00132	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000128	0.00132	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000968	CcSEcCtD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00132	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000966	CcSEcCtD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00131	CbGpPWpGaD
Sulfamethoxazole—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000961	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00131	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000126	0.0013	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.0013	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00128	CbGpPWpGaD
Sulfamethoxazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000935	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000923	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000122	0.00126	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000122	0.00126	CbGpPWpGaD
Sulfamethoxazole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000922	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000921	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000121	0.00125	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000121	0.00125	CbGpPWpGaD
Sulfamethoxazole—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000916	CcSEcCtD
Sulfamethoxazole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000916	CcSEcCtD
Sulfamethoxazole—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00012	0.00124	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000118	0.00122	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000116	0.0012	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000868	CcSEcCtD
Sulfamethoxazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000868	CcSEcCtD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00118	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000112	0.00115	CbGpPWpGaD
Sulfamethoxazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000844	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00084	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00084	CcSEcCtD
Sulfamethoxazole—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000111	0.00114	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00011	0.00114	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00108	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000104	0.00108	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00108	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00107	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000782	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000103	0.00107	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000103	0.00107	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000103	0.00107	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000102	0.00105	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000101	0.00104	CbGpPWpGaD
Sulfamethoxazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000762	CcSEcCtD
Sulfamethoxazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.92e-05	0.000751	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	9.88e-05	0.00102	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.87e-05	0.00102	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	9.84e-05	0.00102	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	9.83e-05	0.00102	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	9.82e-05	0.00101	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.000727	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.41e-05	0.000972	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.39e-05	0.00097	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.29e-05	0.00096	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.27e-05	0.000702	CcSEcCtD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.16e-05	0.000947	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.1e-05	0.00094	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.99e-05	0.000929	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000675	CcSEcCtD
Sulfamethoxazole—Rash—Prednisone—chronic obstructive pulmonary disease	8.84e-05	0.00067	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000669	CcSEcCtD
Sulfamethoxazole—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	8.82e-05	0.000911	CbGpPWpGaD
Sulfamethoxazole—Headache—Prednisone—chronic obstructive pulmonary disease	8.78e-05	0.000665	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.67e-05	0.000896	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	8.52e-05	0.00088	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	8.43e-05	0.000871	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.41e-05	0.000869	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	8.41e-05	0.000868	CbGpPWpGaD
Sulfamethoxazole—Nausea—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000631	CcSEcCtD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.3e-05	0.000858	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	8.03e-05	0.00083	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	7.99e-05	0.000825	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.86e-05	0.000812	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.81e-05	0.000807	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.81e-05	0.000807	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.75e-05	0.0008	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.64e-05	0.000789	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.56e-05	0.000781	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.46e-05	0.00077	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.35e-05	0.00076	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.23e-05	0.000747	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	7.17e-05	0.000741	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.13e-05	0.000737	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	7.13e-05	0.000736	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.12e-05	0.000736	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.02e-05	0.000725	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.83e-05	0.000706	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.82e-05	0.000705	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.78e-05	0.0007	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.75e-05	0.000697	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.66e-05	0.000688	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	6.65e-05	0.000687	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.65e-05	0.000687	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.4e-05	0.000661	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	6.35e-05	0.000656	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.31e-05	0.000651	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.3e-05	0.000651	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	6.28e-05	0.000649	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.22e-05	0.000643	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.18e-05	0.000638	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6e-05	0.00062	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6e-05	0.000619	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.93e-05	0.000613	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	5.8e-05	0.000599	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	5.8e-05	0.000599	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.8e-05	0.000599	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	5.79e-05	0.000598	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	5.75e-05	0.000594	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.72e-05	0.00059	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.57e-05	0.000575	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	5.53e-05	0.000571	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.52e-05	0.000571	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.49e-05	0.000568	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	5.43e-05	0.000561	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.42e-05	0.00056	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	5.42e-05	0.00056	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	5.4e-05	0.000558	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	5.32e-05	0.00055	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	5.11e-05	0.000528	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	5.07e-05	0.000524	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	5.07e-05	0.000523	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.04e-05	0.00052	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.99e-05	0.000515	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.92e-05	0.000509	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.92e-05	0.000508	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.68e-05	0.000483	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.61e-05	0.000476	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.42e-05	0.000457	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.39e-05	0.000454	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ALB—chronic obstructive pulmonary disease	4.28e-05	0.000442	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.16e-05	0.00043	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.1e-05	0.000424	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.1e-05	0.000423	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.01e-05	0.000415	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.94e-05	0.000407	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.87e-05	0.0004	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.85e-05	0.000398	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.82e-05	0.000395	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.77e-05	0.000389	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.74e-05	0.000386	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.72e-05	0.000384	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.63e-05	0.000375	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.62e-05	0.000374	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.6e-05	0.000372	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.59e-05	0.000371	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.58e-05	0.000369	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.57e-05	0.000369	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.57e-05	0.000369	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.55e-05	0.000367	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.55e-05	0.000366	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.5e-05	0.000361	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.48e-05	0.000359	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.35e-05	0.000346	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.28e-05	0.000338	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.25e-05	0.000336	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.24e-05	0.000334	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.15e-05	0.000326	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.02e-05	0.000312	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.96e-05	0.000306	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.93e-05	0.000302	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.93e-05	0.000302	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.92e-05	0.000301	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.9e-05	0.0003	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.85e-05	0.000294	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.77e-05	0.000287	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.73e-05	0.000282	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.67e-05	0.000276	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.65e-05	0.000274	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.000268	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.58e-05	0.000266	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.57e-05	0.000266	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.54e-05	0.000262	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.52e-05	0.00026	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.49e-05	0.000257	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.48e-05	0.000256	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.46e-05	0.000254	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.36e-05	0.000244	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.31e-05	0.000239	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.29e-05	0.000237	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.19e-05	0.000226	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.11e-05	0.000218	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.000212	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.02e-05	0.000209	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.93e-05	0.000199	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.93e-05	0.000199	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.91e-05	0.000197	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000196	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.89e-05	0.000195	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.89e-05	0.000195	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.000194	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.88e-05	0.000194	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.00019	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000185	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.76e-05	0.000182	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.75e-05	0.00018	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.000178	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.000177	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.000164	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000163	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.56e-05	0.000161	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.54e-05	0.000159	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	1.49e-05	0.000154	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.43e-05	0.000148	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.43e-05	0.000147	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.4e-05	0.000145	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.33e-05	0.000137	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.33e-05	0.000137	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000136	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.31e-05	0.000135	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000134	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000134	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.22e-05	0.000126	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.22e-05	0.000126	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.21e-05	0.000125	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000125	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	0.00012	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000119	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000119	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000111	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.06e-05	0.00011	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000106	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.01e-05	0.000105	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1e-05	0.000104	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.91e-06	0.000102	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.4e-06	9.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.26e-06	9.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.53e-06	8.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	7.85e-06	8.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	7.51e-06	7.75e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	7.46e-06	7.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.11e-06	7.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.02e-06	7.25e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.54e-06	6.75e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	6.39e-06	6.6e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.2e-06	6.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	6.11e-06	6.31e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.21e-06	4.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.03e-06	4.16e-05	CbGpPWpGaD
